News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
277,570 Results
Type
Article (9391)
Company Profile (47)
Press Release (268131)
Multimedia
Podcasts (5)
Webinars (4)
Section
Business (74267)
Career Advice (360)
Deals (16438)
Drug Delivery (38)
Drug Development (40985)
Employer Resources (29)
FDA (7544)
Job Trends (5652)
News (140445)
Policy (13277)
Tag
Academia (720)
Accelerated approval (3)
Adcomms (11)
Allergies (48)
Alliances (18686)
ALS (37)
Alzheimer's disease (669)
Antibody-drug conjugate (ADC) (69)
Approvals (7585)
Artificial intelligence (148)
Autoimmune disease (11)
Automation (9)
Bankruptcy (152)
Best Places to Work (5192)
BIOSECURE Act (6)
Biosimilars (32)
Biotechnology (43)
Bladder cancer (67)
Brain cancer (20)
Breast cancer (158)
Cancer (1572)
Cardiovascular disease (103)
Career advice (316)
Career pathing (4)
CAR-T (121)
CDC (6)
Cell therapy (284)
Cervical cancer (15)
Clinical research (34991)
Collaboration (444)
Compensation (123)
Complete response letters (7)
COVID-19 (898)
CRISPR (26)
C-suite (114)
Cystic fibrosis (45)
Data (1872)
Denatured (1)
Depression (24)
Diabetes (142)
Diagnostics (2703)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (64)
Drug pricing (56)
Drug shortages (18)
Duchenne muscular dystrophy (73)
Earnings (36578)
Editorial (16)
Employer branding (1)
Employer resources (24)
Events (37791)
Executive appointments (341)
FDA (8536)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (384)
Gene editing (58)
Generative AI (13)
Gene therapy (186)
GLP-1 (254)
Government (1487)
Grass and pollen (2)
Guidances (150)
Healthcare (7311)
Huntington's disease (8)
IgA nephropathy (21)
Immunology and inflammation (59)
Immuno-oncology (1)
Indications (28)
Infectious disease (976)
Inflammatory bowel disease (75)
Inflation Reduction Act (6)
Influenza (32)
Intellectual property (74)
Interviews (50)
IPO (8772)
IRA (19)
Job creations (745)
Job search strategy (273)
Kidney cancer (10)
Labor market (11)
Layoffs (58)
Leadership (4)
Legal (2421)
Liver cancer (44)
Lung cancer (215)
Lymphoma (120)
Machine learning (5)
Management (8)
Manufacturing (153)
MASH (54)
Medical device (5680)
Medtech (5681)
Mergers & acquisitions (8138)
Metabolic disorders (359)
Multiple sclerosis (52)
NASH (8)
Neurodegenerative disease (39)
Neuropsychiatric disorders (6)
Neuroscience (959)
NextGen: Class of 2025 (1901)
Non-profit (918)
Now hiring (1)
Obesity (171)
Opinion (94)
Ovarian cancer (65)
Pain (57)
Pancreatic cancer (70)
Parkinson's disease (85)
Partnered (7)
Patents (179)
Patient recruitment (87)
Peanut (22)
People (18430)
Pharmaceutical (11)
Pharmacy benefit managers (7)
Phase I (11172)
Phase II (15477)
Phase III (11552)
Pipeline (1097)
Policy (61)
Postmarket research (917)
Preclinical (4153)
Press Release (52)
Prostate cancer (75)
Psychedelics (11)
Radiopharmaceuticals (140)
Rare diseases (203)
Real estate (1513)
Recruiting (9)
Regulatory (10514)
Reports (26)
Research institute (669)
Resumes & cover letters (49)
Rett syndrome (7)
RNA editing (3)
RSV (20)
Schizophrenia (41)
Series A (66)
Series B (49)
Service/supplier (3)
Sickle cell disease (25)
Special edition (4)
Spinal muscular atrophy (34)
Sponsored (18)
Startups (894)
Stomach cancer (6)
Supply chain (30)
Tariffs (8)
The Weekly (3)
Vaccines (237)
Venture capital (9)
Weight loss (91)
Women's health (9)
Worklife (4)
Date
Today (68)
Last 7 days (287)
Last 30 days (1373)
Last 365 days (17243)
2025 (8343)
2024 (18933)
2023 (21244)
2022 (26943)
2021 (29001)
2020 (26412)
2019 (17812)
2018 (13211)
2017 (13846)
2016 (11842)
2015 (14235)
2014 (9954)
2013 (7544)
2012 (7760)
2011 (8467)
2010 (7724)
Location
Africa (244)
Alabama (18)
Alaska (4)
Arizona (64)
Arkansas (4)
Asia (20781)
Australia (5364)
California (3834)
Canada (1349)
China (357)
Colorado (154)
Connecticut (209)
Delaware (89)
Europe (38424)
Florida (559)
Georgia (110)
Idaho (12)
Illinois (279)
India (21)
Indiana (166)
Iowa (5)
Japan (140)
Kansas (19)
Kentucky (6)
Louisiana (5)
Maine (44)
Maryland (475)
Massachusetts (2730)
Michigan (69)
Minnesota (139)
Missouri (45)
Montana (14)
Nebraska (8)
Nevada (53)
New Hampshire (42)
New Jersey (1345)
New Mexico (12)
New York (1155)
North Carolina (512)
North Dakota (3)
Northern California (1733)
Ohio (82)
Oklahoma (2)
Oregon (8)
Pennsylvania (833)
Puerto Rico (10)
Rhode Island (9)
South America (364)
South Carolina (19)
Southern California (1416)
Tennessee (60)
Texas (581)
United States (14004)
Utah (89)
Virginia (98)
Washington D.C. (27)
Washington State (401)
West Virginia (2)
Wisconsin (19)
277,570 Results for "iaso biotherapeutics usa limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adolore BioTherapeutics to Present at Festival of Biologics USA 2025
April 24, 2025
·
3 min read
Comprehensively Covering Multiple Myeloma: IASO Bio’s GPRC5D CAR-T Product RD118 Receives IND Approval from NMPA
IASO Biotechnology (“IASO Bio”) today announces that the investigational new drug (IND) application for RD118, an independently developed, fully human GPRC5D-targeting chimeric antigen receptor T-cell (CAR-T) therapy, has been approved by the National Medical Products Administration (NMPA) for treatment of relapsed/refractory multiple myeloma (RRMM).
June 28, 2024
·
5 min read
Press Releases
ALK enters into neffy® co-promotion agreement in the USA
May 5, 2025
·
3 min read
Press Releases
EnPlusOne Biosciences To Present New Data at TIDES USA
May 15, 2025
·
2 min read
Press Releases
ulrich medical USA® Appoints Eric Gibbs as President and General Manager
May 22, 2025
·
2 min read
Press Releases
Steminent to Showcase Breakthrough MSC-based Therapy for Spinocerebellar Ataxia at WODC USA and ISCT 2025
April 25, 2025
·
2 min read
Biotech Bay
IASO Bio Presented Clinical Data and Single-cell Analysis of Equecabtagene Autoleucel for the Treatment of Central Nervous System Autoimmunity in Oral Presentation at EAN Congress 2024
IASO biotechnology presented the clinical data and single-cell analysis of the fully human anti-BCMA CAR T cell therapy for the treatment of central nervous system autoimmunity in an oral presentation at the 2024 European Academy of Neurology Annual Meeting.
July 1, 2024
·
5 min read
Policy
Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into a Settlement and License Agreement (Agreement) with Cipla Ltd. and Cipla USA, Inc. (collectively Cipla).
May 20, 2024
·
3 min read
Press Releases
Tsingke Biotech Participates in TIDES USA 2025, Demonstrates Full-Scale Oligonucleotide Synthesis Capabilities
June 5, 2025
·
1 min read
Biotech Bay
IASO BIO Announces New Development Partnership with Umoja Biopharma to Develop Ex Vivo and In Vivo Cell and Gene Therapies
IASO Biotherapeutics announced a new set of collaborations with Umoja Biopharma, Inc., a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies in oncology and autoimmunity, for the development and commercialization of novel ex vivo and in vivo cell and gene therapies.
January 3, 2024
·
5 min read
1 of 27,757
Next
